Annual EBITDA
$1.67B$8.83B-84.12%
Summary
- Current Value
- As of today, GILD annual EBITDA is $1.67B, down -84.12% on
- Historical Performance
- GILD annual EBITDA is down -85.29% over the past 3 years, and down -77.95% over the past 5 years
- All-Time High Comparison
- GILD annual EBITDA is currently -92.89% below its historical high of $23.45B set on
- 3-Year Low Comparison
- GILD annual EBITDA is at its 3-year low
- Sector Comparison
- GILD annual EBITDA is higher than 95.34% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.67B | -84.1% | -85.3% | -78.0% | -56.0% | |
| Quarterly EBITDA | $4.22B | +9.4% | +12.9% | +19.9% | +314.4% | |
| TTM EBITDA | $14.10B | +5.7% | +17.7% | +48.1% | +218.7% | |
| Price | $121.60 | +32.4% | +41.6% | +108.7% | +571.1% | |
| PE Ratio | 18.83 | -92.5% | -20.2% | -97.5% | +72.0% | |
| Annual Revenue | $28.73B | +6.2% | +5.0% | +28.7% | +314.6% | |
| Annual EPS | $0.38 | -91.5% | -92.3% | -90.9% | -72.9% | |
| Annual EBIT | $1.67B | -78.6% | -82.0% | -72.9% | -53.3% | |
| Annual Net Income | $480.00M | -91.5% | -92.3% | -91.0% | -81.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $10.50B | -84.1% | |
| 5Y | $11.33B | -85.3% | |
| All | $23.45B | -92.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.67B | at low | |
| 5Y | $1.67B | at low | |
| All | -$106.00M | +1672.7% |
EBITDA History
FAQ
What is the current annual EBITDA of GILD?
As of today, GILD annual EBITDA is $1.67B
What is 1-year change in GILD annual EBITDA?
GILD annual EBITDA is down -84.12% year-over-year
What is 3-year change in GILD annual EBITDA?
GILD annual EBITDA is down -85.29% over the past 3 years
How far is GILD annual EBITDA from its all-time high?
GILD annual EBITDA is currently -92.89% below its historical high of $23.45B set on December 31, 2015
How does GILD annual EBITDA rank versus sector peers?
GILD annual EBITDA is higher than 95.34% of companies in Healthcare sector
When is GILD next annual earnings release?
The next annual earnings release for GILD is on
Quarterly EBITDA
$4.22B$770.00M+22.35%
Summary
- Current Value
- As of today, GILD quarterly EBITDA is $4.22B, up +22.35% on
- Historical Performance
- GILD quarterly EBITDA is up +9.42% year-over-year, and up +12.94% over the past 3 years
- All-Time High Comparison
- GILD quarterly EBITDA is currently -26.94% below its historical high of $5.77B set on
- 3-Year Low Comparison
- GILD quarterly EBITDA is +63.37% above its 3-year low of $2.58B reached on
- Sector Comparison
- GILD quarterly EBITDA is higher than 98.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $4.22B | +22.4% | +9.4% | +12.9% | +19.9% | |
| Annual EBITDA | $1.67B | – | -84.1% | -85.3% | -78.0% | |
| TTM EBITDA | $14.10B | +2.6% | +5.7% | +17.7% | +48.1% | |
| Price | $121.60 | +10.0% | +32.4% | +41.6% | +108.7% | |
| PE Ratio | 18.83 | +10.0% | -92.5% | -20.2% | -97.5% | |
| Quarterly Revenue | $7.78B | +10.2% | +3.4% | +11.3% | +18.6% | |
| Quarterly EPS | $2.43 | +55.8% | +142.2% | +71.5% | +752.5% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Net Income | $3.05B | +55.7% | +143.6% | +70.9% | +764.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.22B | at high | |
| 3Y | $4.22B | at high | |
| 5Y | $4.36B | -3.3% | |
| All | $5.77B | -26.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.20B | N/A | +31.6% |
| 3Y | $2.58B | +63.4% | |
| 5Y | $2.00B | +111.0% | |
| All | -$1.16B | +464.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GILD?
As of today, GILD quarterly EBITDA is $4.22B
What is GILD quarterly EBITDA most recent change?
GILD quarterly EBITDA was up +22.35% on September 30, 2025
What is 1-year change in GILD quarterly EBITDA?
GILD quarterly EBITDA is up +9.42% year-over-year
How far is GILD quarterly EBITDA from its all-time high?
GILD quarterly EBITDA is currently -26.94% below its historical high of $5.77B set on June 30, 2015
How does GILD quarterly EBITDA rank versus sector peers?
GILD quarterly EBITDA is higher than 98.92% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
TTM EBITDA
$14.10B$363.00M+2.64%
Summary
- Current Value
- As of today, GILD TTM EBITDA is $14.10B, up +2.64% on
- Historical Performance
- GILD TTM EBITDA is up +5.65% year-over-year, and up +17.73% over the past 3 years
- All-Time High Comparison
- GILD TTM EBITDA is currently -38.02% below its historical high of $22.76B set on
- 3-Year Low Comparison
- GILD TTM EBITDA is +18.70% above its 3-year low of $11.88B reached on
- Sector Comparison
- GILD TTM EBITDA is higher than 98.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $14.10B | +2.6% | +5.7% | +17.7% | +48.1% | |
| Annual EBITDA | $1.67B | – | -84.1% | -85.3% | -78.0% | |
| Quarterly EBITDA | $4.22B | +22.4% | +9.4% | +12.9% | +19.9% | |
| Price | $121.60 | +10.0% | +32.4% | +41.6% | +108.7% | |
| PE Ratio | 18.83 | +10.0% | -92.5% | -20.2% | -97.5% | |
| TTM Revenue | $29.05B | +0.9% | +2.8% | +7.5% | +26.0% | |
| TTM EPS | $6.46 | +28.4% | +7178.8% | +144.2% | +569.7% | |
| TTM EBIT | $7.81B | -28.8% | -26.3% | -20.9% | -3.8% | |
| TTM Net Income | $8.11B | +28.5% | +7014.0% | +145.1% | +557.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $14.10B | at high | |
| 3Y | $14.10B | at high | |
| 5Y | $14.26B | -1.1% | |
| All | $22.76B | -38.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $13.43B | N/A | +5.0% |
| 3Y | $11.88B | +18.7% | |
| 5Y | $11.62B | N/A | +21.4% |
| All | -$104.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GILD?
As of today, GILD TTM EBITDA is $14.10B
What is GILD TTM EBITDA most recent change?
GILD TTM EBITDA was up +2.64% on September 30, 2025
What is 1-year change in GILD TTM EBITDA?
GILD TTM EBITDA is up +5.65% year-over-year
How far is GILD TTM EBITDA from its all-time high?
GILD TTM EBITDA is currently -38.02% below its historical high of $22.76B set on December 31, 2015
How does GILD TTM EBITDA rank versus sector peers?
GILD TTM EBITDA is higher than 98.73% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
EBITDA Formula
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209525000044/0000882095-25-000044-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild